TTF device plus radiation for lung cancer brain metastases
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a wearable device called Tumor Treating Fields (TTF) combined with targeted radiation (stereotactic radiosurgery) for people with newly diagnosed brain metastases from non-small cell lung cancer. The goal is to see if the electric fields from the device can help control the brain tumors along with the radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been newly diagnosed with brain metastases from non-small cell lung cancer (NSCLC) that have not been treated before.
- Your MRI shows 1–10 brain tumors that cannot be surgically removed.
- Your cancer does not have a 'driver gene' mutation (like EGFR, ALK, or ROS1).
- You are generally healthy enough to care for yourself (Karnofsky score 70 or higher) and expected to live at least 3 more months.
- You can operate the TTF device (a wearable cap that sends electric fields to the brain) on your own or with help from a caregiver.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a targeted radiation treatment for brain tumors that have spread from lung cancer and may not have responded to other treatments. The goal is to see if this precise radiation approach can shrink these tumors and improve survival with fewer side effects.
This trial tests a combination of radiation to the brain plus chemotherapy and immunotherapy (anti-PD-1/PD-L1) for people with newly diagnosed non-small cell lung cancer that has spread to the brain. It is for those whose tumors do not have common driver mutations and whose brain metastases are causing symptoms.
This trial tests a wearable device that puts low-intensity electric fields on the skin over spinal tumors to slow their growth. It's for people whose spinal metastases have already been treated with surgery and/or radiation and have no more radiation options.
This trial tests adding a device that delivers electric fields (Tumor Treating Fields) to standard immunotherapy and chemotherapy for people with advanced non-small cell lung cancer that has not been treated before. It may help slow tumor growth.
This trial tests whether combining brain radiation with chemotherapy and immunotherapy can help people with advanced lung cancer that has spread to the brain but has not yet been treated. It is for those whose tumors do not have certain gene mutations (EGFR, ALK, ROS1).
This trial tests a device that sends low-energy electrical fields (called Tumor Treating Fields) to the lung tumor before surgery. The goal is to see if it can help shrink the tumor and improve surgical outcomes.
Hear when a new NSCLC Brain Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.